379 related articles for article (PubMed ID: 26835711)
1. The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.
Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S
Cancer Biomark; 2016; 16(1):109-15. PubMed ID: 26835711
[TBL] [Abstract][Full Text] [Related]
2. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.
Mohd Suzairi MS; Tan SC; Ahmad Aizat AA; Mohd Aminudin M; Siti Nurfatimah MS; Andee ZD; Ankathil R
Cancer Epidemiol; 2013 Oct; 37(5):634-8. PubMed ID: 23806437
[TBL] [Abstract][Full Text] [Related]
3. A functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal cell carcinoma.
Cai H; Sun L; Cui L; Cao Q; Qin C; Zhang G; Mao X; Wang M; Zhang Z; Shao P; Yin C
Urol Int; 2013; 91(2):206-12. PubMed ID: 23295440
[TBL] [Abstract][Full Text] [Related]
4. The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-κ B1 gene and the risk of urinary cancer.
Li X; Gao Y; Zhou H; Xu W; Li P; Zhou J; Xu T; Yu B; Xu Z; Zou Q; Yin C; Cai H; Shen W
Cancer Biomark; 2016; 16(1):11-7. PubMed ID: 26484607
[TBL] [Abstract][Full Text] [Related]
5. NFKB1 promoter -94 insertion/deletion ATTG polymorphism (rs28362491) is associated with severity and disease progression of rheumatoid arthritis through interleukin-6 levels modulation in Egyptian patients.
Elkhawaga SY; Gomaa MH; Elsayed MM; Ebeed AA
Clin Rheumatol; 2021 Jul; 40(7):2927-2937. PubMed ID: 33459954
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.
Koc A; Batar B; Celik O; Onaran I; Tasan E; Sultuybek GK
Immunobiology; 2014 Jul; 219(7):531-6. PubMed ID: 24703107
[TBL] [Abstract][Full Text] [Related]
7. A functional promoter polymorphism in NFKB1 increases susceptibility to endometriosis.
Zhou B; Rao L; Peng Y; Wang Y; Qie M; Zhang Z; Song Y; Zhang L
DNA Cell Biol; 2010 May; 29(5):235-9. PubMed ID: 20218898
[TBL] [Abstract][Full Text] [Related]
8. Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population.
Li P; Gu J; Yang X; Cai H; Tao J; Yang X; Lu Q; Wang Z; Yin C; Gu M
PLoS One; 2013; 8(8):e71604. PubMed ID: 23977085
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of studies on the association between the NF-κB1-94ins/del ATTG promoter polymorphism and cancer.
Nian X; Zhang W; Li L; Sun Y; Sun E; Han R
Tumour Biol; 2014 Dec; 35(12):11921-31. PubMed ID: 25190017
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the
Chen J; Ge D; Xiong Y
Clin Exp Hypertens; 2019; 41(6):577-582. PubMed ID: 30285510
[No Abstract] [Full Text] [Related]
11. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.
Kurylowicz A; Hiromatsu Y; Jurecka-Lubieniecka B; Kula D; Kowalska M; Ichimura M; Koga H; Kaku H; Bar-Andziak E; Nauman J; Jarzab B; Ploski R; Bednarczuk T
Genes Immun; 2007 Oct; 8(7):532-8. PubMed ID: 17690684
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of NFKB1-94 ATTG Ins/Del Polymorphism and Risk of Breast Cancer.
Kancharla J; Prasad IDV; Bhaskar LVKS; Bramhachari PV; Alam A
Curr Drug Metab; 2020; 21(3):221-225. PubMed ID: 32156231
[TBL] [Abstract][Full Text] [Related]
13. Roles of functional NFKB1 and β-TrCP insertion/deletion polymorphisms in mRNA expression and epithelial ovarian cancer susceptibility.
Huo ZH; Zhong HJ; Zhu YS; Xing B; Tang H
Genet Mol Res; 2013 Mar; 12(3):3435-43. PubMed ID: 23546975
[TBL] [Abstract][Full Text] [Related]
14. Effect of TP53 16-bp and β-TrCP 9-bp INS/DEL polymorphisms in relation to risk of breast cancer.
Eskandari-Nasab E; Hashemi M; Amininia S; Ebrahimi M; Rezaei M; Hashemi SM
Gene; 2015 Sep; 568(2):181-5. PubMed ID: 26003292
[TBL] [Abstract][Full Text] [Related]
15. Association Between the NFKB1-94ins/del ATTG Polymorphism (rs28362491) and Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Chen QJ; Lai HM; Zhao L; Ma YT; Li XM; Zhai H; Zhou Y; He CH; Chen BD; Liu F; Yang YN
Genet Test Mol Biomarkers; 2016 Mar; 20(3):105-11. PubMed ID: 26799199
[TBL] [Abstract][Full Text] [Related]
16. Application of Single-Tube Tri-Primer ARMS-PCR to Detect the NFKB1 ATTG Insertion/Deletion Polymorphism.
Chao J; Chai L; Yin X; Zhou Z; Xu S; Zhu W; Deng Y
Genet Test Mol Biomarkers; 2018 Jul; 22(7):443-447. PubMed ID: 30020835
[TBL] [Abstract][Full Text] [Related]
17. Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients.
Lo SS; Chen JH; Wu CW; Lui WY
Surgery; 2009 Mar; 145(3):280-5. PubMed ID: 19231580
[TBL] [Abstract][Full Text] [Related]
18. An updated meta-analysis of 37 case-control studies on the association between NFKB1 -94ins/del ATTG promoter polymorphism and cancer susceptibility.
Luo YQ; Wang D; Gong T; Zhu J
Oncotarget; 2016 Sep; 7(36):58659-58670. PubMed ID: 27463002
[TBL] [Abstract][Full Text] [Related]
19. Variations in Toll-like receptor and nuclear factor-kappa B genes and the risk of glioma.
Kına I; Sultuybek GK; Soydas T; Yenmis G; Biceroglu H; Dirican A; Uzan M; Ulutin T
Br J Neurosurg; 2019 Apr; 33(2):165-170. PubMed ID: 30450997
[TBL] [Abstract][Full Text] [Related]
20. -94 ATTG insertion/deletion polymorphism of the NFKB1 gene is associated with coronary artery disease in Han and Uygur women in China.
Yang YN; Zhang JY; Ma YT; Xie X; Li XM; Liu F; Chen BD; Dong XH; Zheng YY; Pan S; Zhai H; Li DZ; Chen QJ
Genet Test Mol Biomarkers; 2014 Jun; 18(6):430-8. PubMed ID: 24818816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
